Matthew R. Patterson, Chief Executive Officer at Audentes Therapeutics, Inc. (BOLD), sold 12,952 shares at $40.00 ($518K) on 2018-09-18, disclosed to the SEC on 2018-09-20.
Open-market sale of $518k BOLD by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BOLD | SELL | 2019-02-27 | $630K | — | Filing → |
| BOLD | SELL | 2018-10-02 | $1.6M | — | Filing → |
| BOLD | SELL | 2018-07-05 | $5.6M | — | Filing → |